Skip to main content
Erschienen in:

09.08.2024 | Paediatric

Performance of grayscale combined with contrast-enhanced ultrasound in differentiating benign and malignant pediatric ovarian masses

verfasst von: Zehang Hu, Shumin Fan, Xia Feng, Lei Liu, Jingran Zhou, Zhixia Wu, Luyao Zhou

Erschienen in: European Radiology | Ausgabe 2/2025

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate grayscale US combined with contrast-enhanced ultrasound (CEUS) in the preoperative differentiation between benign and malignant ovarian masses in a pediatric population.

Materials and methods

This retrospective study enrolled patients who underwent grayscale US and CEUS before surgery because of ovarian masses between July 2018 and September 2023, with available histopathologic or follow-up results. Two senior radiologists summarized the grayscale US and CEUS characteristics of all ovarian masses, including percentage of solidity, ascites, vascularity, and enhanced vessel morphology. These characteristics were then independently reviewed by radiologists with different experience to assess interobserver agreement. Diagnostic performance was evaluated using the area under the receiver operating characteristic curve (AUC), while interobserver agreement was evaluated by intraclass correlation coefficient (ICC).

Results

A total of 26 children (median age: 10.1 [7.5, 11.7] years; age range: 0–14 years; benign: 15 patients) were included. The main characteristics of malignant ovarian tumors were abundant blood flow and twisted blood vessels within the mass, enhanced portion of the mass over 50 percent (all p < 0.001). The grayscale US combined with CEUS showed better diagnostic performance than the grayscale US alone (AUC = 0.99 [95% CI: 0.95, 1.00] vs AUC = 0.70 [95% CI: 0.50, 0.90] p < 0.001). A statistically significant AUC before and after CEUS was also shown between two junior radiologists (0.75 vs 0.92 and 0.69 vs 0.86, respectively, both p < 0.05). ICC of CEUS was better than that of grayscale US among radiologists.

Conclusion

The combination of grayscale US and CEUS might improve the diagnostic accuracy in differentiating benign and malignant pediatric ovarian masses.

Clinical relevance statement

Grayscale ultrasound combined with contrast-enhanced ultrasound can improve the diagnostic performance in the preoperative differentiation of benign and malignant ovarian lesions in a pediatric population.

Key Points

  • Correctly distinguishing benign from malignant ovarian masses in pediatric patients is critical for determining treatments.
  • Grayscale combined with contrast-enhanced ultrasound (CEUS) differentiated benign and malignant pediatric ovarian masses better than grayscale US alone.
  • Junior radiologists’ diagnostic performances could be and were significantly improved with the application of CEUS.
Literatur
1.
Zurück zum Zitat Schallert EK, Abbas PI, Mehollin-Ray AR et al (2019) Physiologic ovarian cysts versus other ovarian and adnexal pathologic changes in the preadolescent and adolescent population: US and surgical follow-up. Radiology 292:172–178CrossRefPubMed Schallert EK, Abbas PI, Mehollin-Ray AR et al (2019) Physiologic ovarian cysts versus other ovarian and adnexal pathologic changes in the preadolescent and adolescent population: US and surgical follow-up. Radiology 292:172–178CrossRefPubMed
2.
Zurück zum Zitat Eskander RN, Bristow RE, Saenz NC, Saenz CC (2011) A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses. J Pediatr Adolesc Gynecol 24:282–285CrossRefPubMed Eskander RN, Bristow RE, Saenz NC, Saenz CC (2011) A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses. J Pediatr Adolesc Gynecol 24:282–285CrossRefPubMed
3.
Zurück zum Zitat Kirkham YA, Lacy JA, Kives S, Allen L (2011) Characteristics and management of adnexal masses in a Canadian pediatric and adolescent population. J Obstet Gynaecol Can 33:935–943CrossRefPubMed Kirkham YA, Lacy JA, Kives S, Allen L (2011) Characteristics and management of adnexal masses in a Canadian pediatric and adolescent population. J Obstet Gynaecol Can 33:935–943CrossRefPubMed
4.
5.
Zurück zum Zitat Heo SH, Kim JW, Shin SS et al (2014) Review of ovarian tumors in children and adolescents: radiologic-pathologic correlation. Radiographics 34:2039–2055CrossRefPubMed Heo SH, Kim JW, Shin SS et al (2014) Review of ovarian tumors in children and adolescents: radiologic-pathologic correlation. Radiographics 34:2039–2055CrossRefPubMed
6.
Zurück zum Zitat Querleu D, Planchamp F, Chiva L et al (2017) European Society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer 27:1534–1542CrossRefPubMed Querleu D, Planchamp F, Chiva L et al (2017) European Society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer 27:1534–1542CrossRefPubMed
7.
Zurück zum Zitat Froyman W, Landolfo C, De Cock B et al (2019) Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol 20:448–458CrossRefPubMed Froyman W, Landolfo C, De Cock B et al (2019) Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol 20:448–458CrossRefPubMed
8.
Zurück zum Zitat Hanafy AK, Mujtaba B, Yedururi S et al (2020) Imaging in pediatric ovarian tumors. Abdom Radiol (NY) 45:520–536CrossRefPubMed Hanafy AK, Mujtaba B, Yedururi S et al (2020) Imaging in pediatric ovarian tumors. Abdom Radiol (NY) 45:520–536CrossRefPubMed
9.
Zurück zum Zitat Asăvoaie C, Fufezan O, Coşarcă M (2014) Ovarian and uterine ultrasonography in pediatric patients. Pictorial essay. Med Ultrason 16:160–167CrossRefPubMed Asăvoaie C, Fufezan O, Coşarcă M (2014) Ovarian and uterine ultrasonography in pediatric patients. Pictorial essay. Med Ultrason 16:160–167CrossRefPubMed
10.
Zurück zum Zitat Andreotti RF, Timmerman D, Strachowski LM et al (2020) O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System committee. Radiology 294:168–185CrossRefPubMed Andreotti RF, Timmerman D, Strachowski LM et al (2020) O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System committee. Radiology 294:168–185CrossRefPubMed
11.
Zurück zum Zitat Kaijser J, Vandecaveye V, Deroose CM et al (2014) Imaging techniques for the pre-surgical diagnosis of adnexal tumours. Best Pract Res Clin Obstet Gynaecol 28:683–695CrossRefPubMed Kaijser J, Vandecaveye V, Deroose CM et al (2014) Imaging techniques for the pre-surgical diagnosis of adnexal tumours. Best Pract Res Clin Obstet Gynaecol 28:683–695CrossRefPubMed
12.
Zurück zum Zitat Xun L, Zhai L, Xu H (2021) Comparison of conventional, Doppler and contrast-enhanced ultrasonography in differential diagnosis of ovarian masses: a systematic review and meta-analysis. BMJ Open 11:e052830CrossRefPubMedPubMedCentral Xun L, Zhai L, Xu H (2021) Comparison of conventional, Doppler and contrast-enhanced ultrasonography in differential diagnosis of ovarian masses: a systematic review and meta-analysis. BMJ Open 11:e052830CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Anupindi SA, Biko DM, Ntoulia A et al (2017) Contrast-enhanced US assessment of focal liver lesions in children. Radiographics 37:1632–1647CrossRefPubMed Anupindi SA, Biko DM, Ntoulia A et al (2017) Contrast-enhanced US assessment of focal liver lesions in children. Radiographics 37:1632–1647CrossRefPubMed
15.
Zurück zum Zitat Rafailidis V, Deganello A, Watson T et al (2017) Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications. Br J Radiol 90:20160556CrossRefPubMed Rafailidis V, Deganello A, Watson T et al (2017) Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications. Br J Radiol 90:20160556CrossRefPubMed
16.
Zurück zum Zitat Xu J, Huang Z, Zeng J et al (2023) Value of contrast-enhanced ultrasound parameters in the evaluation of adnexal masses with ovarian-adnexal reporting and data system ultrasound. Ultrasound Med Biol 49:1527–1534CrossRefPubMed Xu J, Huang Z, Zeng J et al (2023) Value of contrast-enhanced ultrasound parameters in the evaluation of adnexal masses with ovarian-adnexal reporting and data system ultrasound. Ultrasound Med Biol 49:1527–1534CrossRefPubMed
17.
Zurück zum Zitat Yuan K, Huang YJ, Mao MY et al (2023) Contrast-enhanced US to improve diagnostic performance of O-RADS US risk stratification system for malignancy. Radiology 308:e223003CrossRefPubMed Yuan K, Huang YJ, Mao MY et al (2023) Contrast-enhanced US to improve diagnostic performance of O-RADS US risk stratification system for malignancy. Radiology 308:e223003CrossRefPubMed
18.
Zurück zum Zitat Qiu L, Yang F, Luo H (2018) A preliminary study: the sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses. Medicine (Baltimore) 97:e11536CrossRefPubMed Qiu L, Yang F, Luo H (2018) A preliminary study: the sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses. Medicine (Baltimore) 97:e11536CrossRefPubMed
19.
Zurück zum Zitat Delaney LJ, Machado P, Torkzaban M et al (2020) Characterization of adnexal masses using contrast-enhanced subharmonic imaging: a pilot study. J Ultrasound Med 39:977–985CrossRefPubMed Delaney LJ, Machado P, Torkzaban M et al (2020) Characterization of adnexal masses using contrast-enhanced subharmonic imaging: a pilot study. J Ultrasound Med 39:977–985CrossRefPubMed
20.
Zurück zum Zitat Xu A, Nie F, Liu T et al (2022) Adnexal masses: diagnostic performance of contrast-enhanced ultrasound using the simple rules from the International Ovarian Tumor Analysis group. Int J Gynaecol Obstet 157:568–573CrossRefPubMed Xu A, Nie F, Liu T et al (2022) Adnexal masses: diagnostic performance of contrast-enhanced ultrasound using the simple rules from the International Ovarian Tumor Analysis group. Int J Gynaecol Obstet 157:568–573CrossRefPubMed
21.
Zurück zum Zitat Zhang X, Mao Y, Zheng R et al (2014) The contribution of qualitative CEUS to the determination of malignancy in adnexal masses, indeterminate on conventional US—a multicenter study. PLoS One 9:e93843CrossRefPubMedPubMedCentral Zhang X, Mao Y, Zheng R et al (2014) The contribution of qualitative CEUS to the determination of malignancy in adnexal masses, indeterminate on conventional US—a multicenter study. PLoS One 9:e93843CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Wu Y, Peng H, Zhao X (2015) Diagnostic performance of contrast-enhanced ultrasound for ovarian cancer: a meta-analysis. Ultrasound Med Biol 41:967–974CrossRefPubMed Wu Y, Peng H, Zhao X (2015) Diagnostic performance of contrast-enhanced ultrasound for ovarian cancer: a meta-analysis. Ultrasound Med Biol 41:967–974CrossRefPubMed
23.
Zurück zum Zitat Zhang W, Wang L, Xin Z (2018) Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer. Medicine (Baltimore) 97:e0358CrossRefPubMed Zhang W, Wang L, Xin Z (2018) Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer. Medicine (Baltimore) 97:e0358CrossRefPubMed
24.
Zurück zum Zitat Riccabona M (2012) Application of a second-generation US contrast agent in infants and children—a European questionnaire-based survey. Pediatr Radiol 42:1471–1480CrossRefPubMed Riccabona M (2012) Application of a second-generation US contrast agent in infants and children—a European questionnaire-based survey. Pediatr Radiol 42:1471–1480CrossRefPubMed
25.
Zurück zum Zitat Jacob J, Deganello A, Sellars ME et al (2013) Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med 34:529–540CrossRefPubMed Jacob J, Deganello A, Sellars ME et al (2013) Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med 34:529–540CrossRefPubMed
26.
Zurück zum Zitat Ma X, Zhao Y, Zhang B et al (2015) Contrast-enhanced ultrasound for differential diagnosis of malignant and benign ovarian tumors: systematic review and meta-analysis. Ultrasound Obstet Gynecol 46:277–283CrossRefPubMed Ma X, Zhao Y, Zhang B et al (2015) Contrast-enhanced ultrasound for differential diagnosis of malignant and benign ovarian tumors: systematic review and meta-analysis. Ultrasound Obstet Gynecol 46:277–283CrossRefPubMed
27.
Zurück zum Zitat Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors—clinical perspectives. Cell Oncol 44:715–737CrossRef Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors—clinical perspectives. Cell Oncol 44:715–737CrossRef
28.
Zurück zum Zitat Chung YE, Kim KW (2015) Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography 34:3–18CrossRefPubMed Chung YE, Kim KW (2015) Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography 34:3–18CrossRefPubMed
29.
Zurück zum Zitat Fernández M, Semela D, Bruix J et al (2009) Angiogenesis in liver disease. J Hepatol 50:604–620CrossRefPubMed Fernández M, Semela D, Bruix J et al (2009) Angiogenesis in liver disease. J Hepatol 50:604–620CrossRefPubMed
30.
Zurück zum Zitat Munn LL (2003) Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov Today 8:396–403CrossRefPubMed Munn LL (2003) Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov Today 8:396–403CrossRefPubMed
Metadaten
Titel
Performance of grayscale combined with contrast-enhanced ultrasound in differentiating benign and malignant pediatric ovarian masses
verfasst von
Zehang Hu
Shumin Fan
Xia Feng
Lei Liu
Jingran Zhou
Zhixia Wu
Luyao Zhou
Publikationsdatum
09.08.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2025
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-024-11011-z

Neu im Fachgebiet Radiologie

Ringen um den richtigen Umgang mit Zufallsbefunden

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Röntgen-Thorax oder LDCT fürs Lungenscreening nach HNSCC?

Personen, die an einem Plattenepithelkarzinom im Kopf-Hals-Bereich erkrankt sind, haben ein erhöhtes Risiko für Metastasen oder zweite Primärmalignome der Lunge. Eine Studie hat untersucht, wie die radiologische Überwachung aussehen sollte.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.